20240018154. NEW INDAZOLE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)
Jump to navigation
Jump to search
Contents
NEW INDAZOLE DERIVATIVES
Organization Name
Inventor(s)
Cosimo Dolente of Allschwil (CH)
Annick Goergler of Colmar (FR)
David Stephen Hewings of Abingdon (GB)
Christa Ulrike Obst-sander of Reinach BL (CH)
Antonio Ricci of Biel-Benken (CH)
NEW INDAZOLE DERIVATIVES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240018154 titled 'NEW INDAZOLE DERIVATIVES
Simplified Explanation
The invention described in the patent application is a compound of formula (i) or a pharmaceutically acceptable salt thereof. The compound can be used as a medicament.
- The compound of formula (i) or its salt is the subject of the invention.
- The compound has potential applications as a medicament.
- The patent application provides a simplified explanation of the compound and its potential uses.
- The compound is defined by the variables R and A, which are further described in the description and claims of the patent application.
- The invention is not oversold and the abstract does not provide a title.
Potential Applications
- The compound can be used as a medicament in various medical treatments.
- It may have applications in the treatment of specific diseases or conditions, although these are not specified in the abstract.
Problems Solved
- The invention addresses the need for new compounds or salts that can be used as medicaments.
- It potentially solves problems related to the treatment of certain diseases or conditions, although specific problems are not mentioned in the abstract.
Benefits
- The compound of formula (i) or its salt offers a new option for medicament development.
- It may provide improved efficacy or reduced side effects compared to existing medications, although this is not explicitly stated in the abstract.
Original Abstract Submitted
the invention relates to a compound of formula (i) or a pharmaceutically acceptable salt thereof, wherein r-rand a are as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.